Skip to main content
. 2024 Oct 9;16(10):1582. doi: 10.3390/v16101582

Table 3.

Seroprevalence of SARS-CoV-2 by province.

Provinces Population Size Sex Mean Age, Years (SD) Comorbid Conditions SARS-CoV-2 Vaccination Seroprevalence,% (95% CI)
Male,
n (%)
Yes,
n (%)
No,
n (%)
Yes,
n (%)
No,
n (%)
Estuaire 1890 967 (51.2) 36 (16) 173 (9.2) 1717 (90.8) 139 (7.4) 1751 (92.6) 89.9 (88–90)
Haut Ogooué 504 239 (47.4) 33 (21) 21 (4.2) 483 (95.8) 33 (6.5) 471 (93.5) 85.8 (83–89)
Moyen Ogooué 134 59 (44) 29 (21) 21 (15.7) 113 (84.3) 12 (9) 122 (91) 85.2 (78–91)
Ngounié 181 84 (46.4) 33 (23) 18 (9.9) 163 (90.1) 8 (4.4) 173 (95.6) 77.2 (71–83)
Nyanga 75 43 (57.3) 36 (23) 5 (6.7) 70 (93.3) 3 (4) 72 (96) 72.8 (64–81)
Ogooué Ivindo 171 93 (54.4) 27 (21) 13 (7.6) 158 (92.4) 15 (8.8) 156 (91.2) 78.4 (72–84)
Ogooué Lolo 121 61 (50.4) 35 (21) 15 (12.4) 106 (87.6) 9 (7.4) 112 (92.6) 92.7 (87–96)
Ogooué Maritime 272 128 (47.1) 38 (16) 13 (4.8) 259 (95.2) 19 (7) 253 (93) 81.7 (77–86)
Woleu-Ntem 272 121 (44.5) 26 (17) 8 (2.9) 264 (97.1) 13 (4.8) 259 (95.2) 87.5 (83–91)

CI, confidence interval; SD, standard deviation; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.